These findings on DRP1 were extended to a murine model of diabetic atherosclerosis (T1D-like streptozotocin-induced diabetes in Apoe null mice); in that work, treatment of these mice with a potent and selective inhibitor of DRP1, mitochondrial division inhibitor 1, reduced atherosclerosis in the diabetic mice. Here, DNM1L is linked to atherosclerosis.